The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 09, 2024
Filed:
Nov. 30, 2020
Applicant:
Kyowa Kirin Co., Ltd., Tokyo, JP;
Inventors:
Hiroki Haniuda, Tokyo, JP;
Sachiko Enokizono, Tokyo, JP;
Tomoyuki Nakazato, Tokyo, JP;
Takuya Tokuda, Tokyo, JP;
Norie Fujiki, Tokyo, JP;
Assignee:
KYOWA KIRIN CO., LTD., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 47/02 (2006.01); A61K 47/14 (2017.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4709 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 47/02 (2013.01); A61K 47/14 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01);
Abstract
The present invention relates to a therapeutic agent for an ophthalmic disease comprising a vascular endothelial growth factor (VEGF) receptor inhibitor or an epidermal growth factor (EGF) receptor inhibitor in a nanoparticle form, having a property to be retained in a posterior eye tissue when systemically administered.
Haniuda, Hiroki. (2024). Pharmaceutical composition (U.S. Patent No. 11951103). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11951103
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile